Azilsartan (medoxomil) - CAS# 863031-21-4 L 13-27 3'-biindol]-2-one

3'-biindol]-2-one

GTS-21 bound to human α4β2 nAChR (Ki=20 nM) 100-fold more potently than to humanα7-nAChR

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

InChi: InChI=1S/C20H24O4/c1-13(8-15-4-6-17(21)19(10-15)22-3)14(2)9-16-5-7-18-20(11-16)24-12-23-18/h4-7

Erlotinib HCl (1 μM) induces apoptosis in DiFi humancolon cancer cells

Azilsartan (medoxomil) - CAS# 863031-21-4 L 13-27 3'-biindol]-2-oneAzilsartan medoxomil also known as TAK 491, is an orally administered angiotensin II receptor type 1 antagonist (blocker) used in the treatment of adults with essential hypertension. Azilsartan medoxomil is a useful and attractive new option for lowering BP in patients with essential hypertension, particularly for those not able to tolerate other antihypertensive drugs. Further studies are required to evaluate the effects of azilsartan medoxomil on